On-line extraction coupled with liquid chromatography tandem mass spectrometry for quantitation of pravastatin and its metabolite in human serum

Biomedical Chromatography

Volumn 22, Issue 7, 2008, Pages 719-726

  Wang, Xiaodong ^a   Wang, Yongcheng ^b  

^a Shandong Analysis and Test Center   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

LC MS MS quantitation; On line extraction; Pravastatin

Indexed keywords

BODY FLUIDS; DIRECT INJECTION; EXTRACTION; FORMIC ACID; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

ANALYTES; EXTRACTION COLUMNS; HIGH-THROUGHPUT; HUMAN SERUM; LC-MS-MS; LC-MS/MS QUANTITATION; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; ONLINE EXTRACTION; PRAVASTATIN;

METABOLITES;

PRAVASTATIN;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ISOLATION; HUMAN; LIQUID CHROMATOGRAPHY; ONLINE ANALYSIS; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY;

EID: 48349118984     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.989     Document Type: Article

References (13)

1. Ayrton J, Dear GJ, Leavens WJ, Mallet DN and Plumb RS. The use of turbulent flow chromatography/mass spectrometry for the rapid, direct analysis of a novel pharmaceutical compound in plasma. Rapid Communications in Mass Spectrometry 1997; 11: 1953-1958.
2. Ayrton J, Dear GJ, Leavens WJ, Mallet DN and Plumb RS. Optimisation and routine use of generic ultra-high flow-rate liquid chromatography with mass spectrometric detection for the direct on-line analysis of pharmaceuticals in plasma. Journal of Chromatography A 1998; 828: 199-207.
3. Dobs AS, Sarma PS and Schterngart D. Long-term endocrine function in hypercholesterolemic patients treated with pravastatin, a new 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor. Metabolism 1993; 42: 1146-1152.
4. Funke PT, Ivashkiv E, Arnold ME and Cohen AI. Determination of pravastatin sodium and its major metabolites in human serum/plasma by capillary gas chromatography/negative ion chemical ionization mass spectrometry. Biomedical and Environmental Mass Spectrometry 1989; 18: 904-909.
5. Jain DS, Subbaiah G, Sanyal M, Jain VK and Shrivastav P. A rapid and specific approach for direct measurement of pravastatin concentration in plasma by LC-MS/MS employing solid-phase extraction. Biomedical Chromatography 2007; 21: 67-78.
6. Jemal M, Xia Y-Q and Whigan DB. A versatile system of high-flow high performance liquid chromatography with tandem mass spectrometry for rapid direct-injection analysis of plasma samples for quantitation of a β-lactam drug candidate and its open-ring biotransformation product. Rapid Communications in Mass Spectrometry 1998; 12: 1389-1399.
7. Jemal M and Xia Y-Q. The need for adequate chromatographic separation in the quantitative determination of drugs in biological samples by high performance liquid chromatography with tandem mass spectrometry. Rapid Communications in Mass Spectrometry 1999; 13: 97-106.
8. Kawabata K, Matsushima N and Sasahara K. An automated method for the simultaneous determination of pravastatin and its main metabolite in human plasma by high-performance liquid chromatography/atmospheric pressure chemical ionization mass spectrometry. Biomedical Chromatography 1998; 12: 271-275.
9. Morris MJ, Gilbert JD, Hsieh JY, Matuszewski BK, Ramjit HG and Bayne WF. Determination of the HMG-CoA reductase inhibitors simvastatin, lovastatin, and pravastatin in plasma by gas chromatography/chemical ionization mass spectrometry. Biology and Mass Spectrometry 1993; 22: 1-8.
10. Mulvana D, Jemal M and Pulver SC. Quantitative determination of pravastatin and its biotransformation products in human serum by turbo ion spray LC/MS/MS. Journal of Pharmaceutical and Biomedical Analysis 2000; 23: 851-866.
11. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JMO, Wun C-C, Davis BR and Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. New England Journal of Medicine 1996; 335: 1001-1009.
12. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, McKillop JH and Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. New England Journal of Medicine 1995; 333: 1301-1307.
13. Whigan DB, Ivashkiv E and Cohen AI. Determination of pravastatin sodium and its isomeric metabolite in human urine by HPLC with UV detection. Journal of Pharmaceutical Biomedical Analysis 1989; 7: 907-912.